| Gregory Nguyenduc, MD | |
|
600 S Dobson Rd Bldg A, Chandler, AZ 85224-5678 | |
| (480) 786-6655 | |
| Not Available |
| Full Name | Gregory Nguyenduc |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 26 Years |
| Location | 600 S Dobson Rd Bldg A, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326016239 | NPI | - | NPPES |
| 463520 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 35213 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Digestive Health Pc | 6507940731 | 79 |
News Archive
F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD).
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.
› Verified 2 days ago
| Entity Name | East Valley Gastroenterology And Hepatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801842737 PECOS PAC ID: 7113916024 Enrollment ID: O20040506001673 |
News Archive
F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD).
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.
› Verified 2 days ago
| Entity Name | Arizona Digestive Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992981583 PECOS PAC ID: 6507940731 Enrollment ID: O20080227000334 |
News Archive
F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD).
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.
› Verified 2 days ago
| Entity Name | Chandler Anesthesia Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669703419 PECOS PAC ID: 2062541139 Enrollment ID: O20100527000709 |
News Archive
F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD).
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Nguyenduc, MD Po Box 6190, Chandler, AZ 85246-6190 Ph: (480) 786-6655 | Gregory Nguyenduc, MD 600 S Dobson Rd Bldg A, Chandler, AZ 85224-5678 Ph: (480) 786-6655 |
News Archive
F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD).
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.
› Verified 2 days ago
Dr. Jaskanwal Singh Bisla, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-428-5500 | |
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Dr. Edward Markman, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-926-0170 |